tiprankstipranks
GeoVax Labs Secures Growth Funding Through Equity Sales
Company Announcements

GeoVax Labs Secures Growth Funding Through Equity Sales

Don't Miss our Black Friday Offers:

GeoVax Labs (GOVX) has shared an announcement.

GeoVax Labs, Inc. has successfully completed a registered direct offering, selling over 1.3 million shares and pre-funded warrants, alongside a concurrent private placement of common warrants. The offering was priced at $5 per share, with net proceeds amounting to approximately $7.85 million to be used for general corporate purposes. The company has also agreed to a 15-day lock-up period post-offering and a six-month ban on certain variable rate transactions, ensuring stability for investors. This strategic financial move aims to bolster GeoVax’s working capital and drive future growth.

For an in-depth examination of GOVX stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyGeoVax Labs announces interim data from Phase 2 trial of Vaccine technology
TipRanks Auto-Generated NewsdeskGeoVax Labs Reports Improved Earnings and Strategic Progress
TheFlyGeoVax Labs reports Q3 EPS (91c), consensus ($1.48)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App